Use of medical care during pandemic (h1n1) 2009, navarre,spain

Emerging Infectious Diseases

Volumn 17, Issue 8, 2011, Pages 1463-1466

  Burgui, Rosana ^a,b   Martínez Baz, Iván ^a,b   Guevara, Marcela ^a,b   Carlos, Silvia ^c   Castilla, Jesús ^a,b  

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CIGARETTE SMOKING; CONSULTATION; CONTROLLED STUDY; FEMALE; FLU LIKE SYNDROME; HEALTH CARE UTILIZATION; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; SCHOOL CHILD; SEASONAL INFLUENZA; SEX DIFFERENCE; SPAIN; STRUCTURED QUESTIONNAIRE; URBAN RURAL DIFFERENCE;

ADOLESCENT; ADULT; CHILD; DELIVERY OF HEALTH CARE; FAMILY CHARACTERISTICS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERVIEWS AS TOPIC; MALE; PANDEMICS; QUESTIONNAIRES; SPAIN; YOUNG ADULT;

EID: 79960867431     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1708.101817     Document Type: Article

References (12)

1. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003;362:1733-45. doi:10.1016/S0140-6736(03)14854-4
2. Heymann DL. Control of communicable diseases manual, 19th ed. Washington: American Public Health Association; 2008.
3. World Health Organization. WHO Regional Office for Europe guidance for influenza surveillance in humans. Copenhagen: WHO Regional Office for Europe; 2009 [cited 2011 Feb 23]. http://www.euro.who.int/__data/assets/pdf_file/0020/90443/E92738.pdf
4. Belongia EA, Irving SA, Waring SC, Coleman KA, Meece JK, Vandermause M, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. JAMA. 2010;304:1091-8. doi:10.1001/jama.2010.1277
5. European Centre for Disease Prevention and Control. European Influenza Surveillance Network (EISN) [cited 2011 Feb 24]. http://ecdc.europa.eu/en/activities/surveillance/EISN/Pages/index.aspx
6. Castilla J, Morán J, Fernández-Alonso M, Martínez Artola V, Zamora MJ, Mazón A, et al. The 2009 H1N1 flu pandemic in Navarre, Spain [in Spanish]. An Sist Sanit Navar. 2010;33:287-95.
7. Wang X, Yang P, Seale H, Zhang Y, Deng Y, Pang X, et al. Estimate of the true number of cases of pandemic (H1N1) 2009, Beijing, China. Emerg Infect Dis. 2010;16:1786-8.
8. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med. 2009;361:2619-27. doi:10.1056/NEJMoa0905498
9. Carrasco-Garrido P, Jiménez-García R, Barrera VH, Gil de Miguel A. Predictive factors of self-medicated drug use among the Spanish adult population. Pharmacoepidemiol Drug Saf. 2008;17:193-9. doi:10.1002/pds.1455
10. Grigoryan L, Burgerhof JGM, Haaijer-Ruskamp FM, Degener JE, Deschepper R, Monnet DL, et al. Is self-medication with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother. 2007;59:152-6. doi:10.1093/jac/dkl457
11. Keech M, Beardsworth P. The impact of influenza on working days lost: a review of the literature. Pharmacoeconomics. 2008;26:911-24. doi:10.2165/00019053-200826110-00004
12. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain A, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-15. doi:10.1056/NEJMoa0903810